New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Molecular Diagnostics, Prostate |
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Clinical Chemistry |
A new study reveals that personalized setpoints in complete blood count tests could enable earlier of diseases.
Read MorePosted by Andy Lundin | Dec 6, 2024 | Cancer |
The cancer screening system, combining AI with trained sniffer dogs, achieved groundbreaking accuracy in detecting early-stage cancers.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Microscopy |
A new AI-driven tool enables neurosurgeons to detect residual brain tumor tissue in seconds, reducing the likelihood of cancer recurrence.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Breast |
Alverno Laboratories has expanded its use of Ibex’s AI-powered cancer diagnostics platform to include breast cancer detection for patients.
Read More